News
New First-Line Treatment Option for BRAF V600E–Mutant Metastatic Colorectal Cancer
January 2026 Some individuals with metastatic colorectal cancer have a specific genetic change called BRAF V600E. This mutation is linked to faster-growing...
Impact of physical activity on fatigue and quality of life in non-metastatic colorectal cancer
January 2026 Results from the International ColoCare Study were presented at this year's ASCO GI Symposium and found that greater levels of...
Is there a link between food preservatives and greater risk for cancer?
January 2026 A French study published in The BMJ found that higher intake of food preservatives, additives that are used in industrially processed foods and drinks...
New US study shows that CRC is the number one cause of cancer death in people under 50
A new study published in the Journal of the American Medical Association looked at cancer deaths in people younger than 50 in the U.S. from...
Nonoperative Management After Total Neoadjuvant Therapy in Rectal Cancer
A recent Italian phase II clinical trial (NO-CUT), published in The Lancet Oncology, evaluated whether some patients with stage II–III rectal cancer can...
The ATOMIC study: atezolizumab plus FOLFOX chemotherapy significantly improves disease-free survival and reduces the risk of recurrence in stage III colon cancer
A new study - the ATOMIC trial - has found that adding the immunotherapy atezolizumab to standard chemotherapy (FOLFOX) significantly improves outcomes for people with...
Get social
New First-Line Treatment Option for BRAF V600E–Mutant Metastatic Colorectal Cancer
January 2026 Some individuals with metastatic colorectal cancer have a specific genetic change called BRAF V600E. This mutation is linked to faster-growing...
Impact of physical activity on fatigue and quality of life in non-metastatic colorectal cancer
January 2026 Results from the International ColoCare Study were presented at this year's ASCO GI Symposium and found that greater levels of...
Is there a link between food preservatives and greater risk for cancer?
January 2026 A French study published in The BMJ found that higher intake of food preservatives, additives that are used in industrially processed foods and drinks...
New US study shows that CRC is the number one cause of cancer death in people under 50
A new study published in the Journal of the American Medical Association looked at cancer deaths in people younger than 50 in the U.S. from...
Nonoperative Management After Total Neoadjuvant Therapy in Rectal Cancer
A recent Italian phase II clinical trial (NO-CUT), published in The Lancet Oncology, evaluated whether some patients with stage II–III rectal cancer can...
The ATOMIC study: atezolizumab plus FOLFOX chemotherapy significantly improves disease-free survival and reduces the risk of recurrence in stage III colon cancer
A new study - the ATOMIC trial - has found that adding the immunotherapy atezolizumab to standard chemotherapy (FOLFOX) significantly improves outcomes for people with...
